Skip to main content
SpringerLink
Log in

Advances in artificial lungs

  • Minireview
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Artificial lungs have already been developed as complete artificial organs, and results of many investigations based on innovative concepts have been reported continuously. In open-heart surgery, artificial lungs are used for extracorporeal circulation to maintain gas exchange, and the commercial products currently available perform adequately, including providing for antithrombogenicity. However, patients after cardiopulmonary arrest or severe respiratory/circulatory failure have required long-term assist with extracorporeal membrane oxygenation (ECMO). The number of artificial lungs used for ECMO in those cases has shown significant growth in recent years. Therefore, it is expected that durability and antithrombogenicity will ensure the prolonged use of an artificial lung for several weeks or months. Furthermore, interests in research are shifting to use of oxygenators as a bridge to lung transplantation and an implantable artificial lung. This paper discusses recent advances in artificial lungs, focusing on the current state and on trends in research and development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ichiba S. An annual questionnaire survey of the Japanese Society of Research on Membrane Oxygenators in 2005 (in Japanese). Membr Oxygen. 2006;29:5–15.

    Google Scholar 

  2. Ichiba S. An annual questionnaire survey of the Japanese Society of Research on Membrane Oxygenators in 2006 (in Japanese). Membr Oxygen. 2007;30:4–8.

    Google Scholar 

  3. Nakatani T. Registry. In: Matsuda H, editor. Percutaneous cardiopulmonary support. Tokyo: Shujunsha; 2004. p. 141–8 (in Japanese).

  4. Yada I, Wada H, Fujita H. Thoracic and cardiovascular surgery in Japan during 2002. Annual report by The Japanese Association for Thoracic Surgery. Jpn J Thorac Cardiovasc Surg. 2004;52:491–508.

    Article  Google Scholar 

  5. The Yano Research Institute. Medical Bionics (Artificial Organs) Market 2007. Tokyo: The Yano Research Institute Ltd; 2007 (in Japanese).

  6. Conrad SA, Rycus PT, Dalton H. Extracorporeal life support registry report 2004. ASAIO J. 2005;51:4–10.

    Article  PubMed  Google Scholar 

  7. Kamiyashiki S, Someya T, Hashimoto K. Benefits of cardiopulmonary bypass using a heparin-coating circuit in subclinical plasma coagulation and fibrinolysis (in Japanese). Jpn J Artif Organs. 1998;28:377–82.

    Google Scholar 

  8. Nishinaka T, Tatsumi E, Katagiri N, Ohnishi H, Mizuno T, Shioya K, et al. Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator. J Artif Organs. 2007;10:240–4.

    Article  CAS  PubMed  Google Scholar 

  9. Kuroiwa K, Funakubo A, Yaguchi T, Sumikura H, Higami T, Fukui Y. Minimization of stagnation area in an artificial lung by multi-step MOGA designs method. ASAIO J. 2008;54:61A. (abstract).

    Google Scholar 

  10. Wang D, Zhou X, Lick SD, Liu X, Qian K, Zwischenberger JB. An ambulatory pulmonary and right heart assist device (OxyRVAD) in an ovine survival model. J Heart Lung Transplant. 2007;26:974–9.

    Article  PubMed  Google Scholar 

  11. Zwischenberger JB, Wang D, Benkowski RJ. The paracorporeal artificial lung: transthoracic total support or percutaneous near total support, which is better? ASAIO J. 2007;36:S-2. (abstract).

    Google Scholar 

  12. Kaji Y. Current status and future of Novalung (in Japanese). Membr Oxygen. 2007;30:50–2.

    Google Scholar 

  13. Mortensen JD. An intravenacaval blood gas exchange (IVCBGE) device: preliminary report. Trans Am Soc Artif Intern Organs. 1987;33:570.

    CAS  Google Scholar 

  14. Lund LW, Hattler BG, Federspiel WJ. A comparative in vitro hemolysis study of a pulsating intravenous artificial lung. ASAIO J. 2002;48:631–5.

    Article  CAS  PubMed  Google Scholar 

  15. Svitek RG, Frankowski BJ, Federspiel WJ. The effect of bundle porosity on the performance of a pumping paracorporeal assist lung using a rotating fiber bundle. ASAIO J. 2005;51:52A. (abstract).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency and General Medicine, Koshimizu Red Cross Hospital, 645-16 Koshimizu, Koshimizu-cho, Shari-gun, Hokkaido, 099-3624, Japan

    Kei Ota

Authors
  1. Kei Ota
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kei Ota.

Additional information

This article is a translation of an article that appeared in The Japanese Journal of Artificial Organs 2008;37:148–150.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ota, K. Advances in artificial lungs. J Artif Organs 13, 13–16 (2010). https://doi.org/10.1007/s10047-010-0492-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-010-0492-1

Keywords

Search

Navigation